InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,969.71
(
0.69%
)
US TECH 100
20,495.60
(
1.35%
)
Dow Jones
43,765.19
(
0.08%
)
Brent Oil
75.61
(
0.71%
)
Bitcoin
76,244.62
(
0.79%
)

Replies to post #43620 on Titan Medical Inc (TMDIF)

Replies to #43620 on Titan Medical Inc (TMDIF)
icon url

DRG1025

08/30/16 11:33 AM

#43621 RE: URspider #43620

I'm pretty confident there would be a third party valuation of some sort. I was apart of a publicly owned company years ago that was bought out. The acquiring company simply didn't pay the current share price. There was a lot more to it than that. Granted, the company had revenue so I'm not sure how Titan's evaluation would go, seeing it has no revenue. But there's more than just share price that goes into it. Regardless if the company has revenue or not.

Value of technology, value of patents, value of the units already built etc. I'm sure there would be other factors considered in the valuation.
icon url

DRG1025

08/30/16 11:33 AM

#43622 RE: URspider #43620

I'm pretty confident there would be a third party valuation of some sort. I was apart of a publicly owned company years ago that was bought out. The acquiring company simply didn't pay the current share price. There was a lot more to it than that. Granted, the company had revenue so I'm not sure how Titan's evaluation would go, seeing it has no revenue. But there's more than just share price that goes into it. Regardless if the company has revenue or not.

Value of technology, value of patents, value of the units already built etc. I'm sure there would be other factors considered in the valuation.
icon url

Bristol19

08/30/16 11:38 AM

#43623 RE: URspider #43620

My newest take:
Fowler fully expects or knows that Titan will is going on the block for sale.

He does not want to be beholden to any acquirer negotiations so he got out now. Likely any acquirer will be glad to rehire him ASAP.

Problems for us: Acquiring Titan is very complicated since Ximedica is so heavily involved as the technical shop; Vanderbilt and others own IP; Longtai has been made promises; other suppliers and manufacturers and educational facilities were probably made promises.

Any reasonable opinions out there on what Titan could sell for?
Let's face it, although unapproved as of yet, this robot is virtually ready to go. Titan's website finally reflects to quality and potential of this device.

Is it all worth a billion and a dice-roll for FDA approval?